London Metropolitan University

Course Introduction

The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work. The aims of this course are to: Provide you with an in'depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving; review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease; enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data; deliver a programme of advanced study to equip you for a future career in anti'cancer drug development.

Course Modules

Core modules: Molecular oncology; cancer pharmacology; cancer (diagnosis and treatment); molecular genetics; scientific frameworks for research; research project. Optional modules: Drug discovery technology; advanced drug formulation technologies; bioinformatics and molecular modelling.

Course Additional Entry

The normal academic standard for entry is a lower 2nd (2.2) UK 1st degree in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics. These will be considered on an individual basis. Equivalent overseas qualifications will also be accepted. All applicants must be able to demonstrate proficiency in the English language.

Duration & Attendance Qualification Tuition fees
1 year
Full Time
MSc (Postgraduate) £11,700  Academic year. First year overseas fees
1 year
Full Time
MSc (Postgraduate) £7,965  Academic year. First year home fees
2 years
Part Time
MSc (Postgraduate) £885  Credit module. First year home fees